Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.
1
Perfecting Partnerships for Life
Sciences Startup Success
21 MARCH | Basel
Moderated by:
Stephan Emmerth,
Director, Ther...
About BaselArea
Main activities
Develop the regional innovation ecosystem
and provide start-up support in
• Therapeutics a...
Foreign Direct
Investment
Start-up Acceleration
& Incubation
Catalyst
Projects
Community
Events, Seminars
& Workshops
Coll...
Building
transformative
biotech
ventures
What we do
Deep validation by selection panel
Industry access
& expertise
Senior team
build-out Infrastructure
Non-dilutiv...
How we do it
Selection Committee
• Anaveon`s $35 Mio Series A led by Syncona
and joined by the Novartis Venture Fund
• Polyneuron`s $22.5 Mio Series A by S...
8
JLABS @ BE –
the EMEA gateway to JLABS
and big company benefits
Guenter Huhle
Head of JLABS EMEA, Johnson & Johnson Inno...
9
Johnson & Johnson Innovation – JLABS is a premier life science incubator
program and a global network of open innovation...
10
SAN DIEGO
January 2012
LOWELL, MASS
JLABS @ M2D2
December 2016
HOUSTON
JLABS @ TMC
March 2016
SHANGHAI
JLABS @ Shanghai...
11
Activating Collaborative Local Ecosystems
building a coalition of academic institutions,
hospitals & industry organizat...
12
Perfecting Partnerships for Life
Sciences Startup Success
21 MARCH | Basel
Moderated by:
Stephan Emmerth,
Director, The...
Nächste SlideShare
Wird geladen in …5
×

Perfecting Partnerships with BaseLaunch and JLABS

118 Aufrufe

Veröffentlicht am

Intro slides from the event about Perfecting Partnerships for Life Sciences Startup Success co-organized by BaseLaunch operated by BaselArea.swiss and JLABS operated by Johnson & Johnson Innovation. The panel of seasoned deal makers included Sascha Bucher, Head Basel Roivant Pharma and Head of Global Transactions, Dominik Escher, Managing Partner BB Pureos Bioventures, Guenther Huhle, Head of JLABS EMEA, Johnson & Johnson Innovation, Carole Nuechterlein, Head of Roche Venture Fund and Markus Werner, VP Partnering of Molecular Partners.

You find the event report here: https://www.baselaunch.ch/event-impressions-key-quotes-perfecting-partnerships-life-sciences-startup-success/

Veröffentlicht in: Gesundheitswesen
  • Als Erste(r) kommentieren

  • Gehören Sie zu den Ersten, denen das gefällt!

Perfecting Partnerships with BaseLaunch and JLABS

  1. 1. 1 Perfecting Partnerships for Life Sciences Startup Success 21 MARCH | Basel Moderated by: Stephan Emmerth, Director, Therapeutic Innovation and BaseLaunch @ BaselArea Sascha Bucher Dominik Escher Guenter Huhle Carole Nuechterlein Markus Werner Head of Basel Roivant Pharma and Head of Global Transactions Partner at Pureos Bioventures Head of JLABS EMEA, Johnson & Johnson Innovation Head of Roche Venture Fund VP Partnering of Molecular Partners
  2. 2. About BaselArea Main activities Develop the regional innovation ecosystem and provide start-up support in • Therapeutics and Biotech • Healthcare • Production & Industry Lead foreign direct investment activities Manage the Switzerland Innovation Park Basel Area
  3. 3. Foreign Direct Investment Start-up Acceleration & Incubation Catalyst Projects Community Events, Seminars & Workshops Collaborative Workspaces Strategic activities reinforcing each other across all focus industries Events, Seminars, Workshops Catalyst Projects Foreign Direct Investment Community Start-up Acceleration & Incubation Collaborative projects that tackle bottleneck issues in innovation How we do it A vibrant community connecting innovators, entrepreneurs, enthusiasts and experts in all our focus industries Different formals to inform and connect community, drive collaboration, agenda setting, and awareness Space as neutral ground for work and co-creation. Space for start-up acceleration 1 2 6 3 Advice during site selection process. Support during relocation and settlement Individual Support during company foundation. Connection to experts and investors 4 5
  4. 4. Building transformative biotech ventures
  5. 5. What we do Deep validation by selection panel Industry access & expertise Senior team build-out Infrastructure Non-dilutive funding up to $250k Derisking early stage ventures, both the science and the business
  6. 6. How we do it Selection Committee
  7. 7. • Anaveon`s $35 Mio Series A led by Syncona and joined by the Novartis Venture Fund • Polyneuron`s $22.5 Mio Series A by Sofinnova and NEA • More to come… Thorough selection primes for success
  8. 8. 8 JLABS @ BE – the EMEA gateway to JLABS and big company benefits Guenter Huhle Head of JLABS EMEA, Johnson & Johnson Innovation
  9. 9. 9 Johnson & Johnson Innovation – JLABS is a premier life science incubator program and a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-enhancing health and wellness solutions to patients around the world. As a leader in innovation, JLABS helps entrepreneurs in pharmaceutical, medical device, consumer, and health tech bring healthcare solutions to patients and consumers. What is JLABS? https://jlabs.jnjinnovation.com
  10. 10. 10 SAN DIEGO January 2012 LOWELL, MASS JLABS @ M2D2 December 2016 HOUSTON JLABS @ TMC March 2016 SHANGHAI JLABS @ Shanghai Opening 2019 TORONTO JLABS @ TORONTO September 2015 BOSTON JLABS @ LABCENTRAL June 2013 BOSTON IC NYC JLABS @ NYC June 2018 SOUTH SAN FRANCISCO JLABS @ SSF January 2013 BAY AREA JLABS @ MBC BioLabs June 2015 SAN FRANCISCO IC JPOD @ Boston January 2019 JLABS JPOD JLABS PARTNERSHIPS INNOVATION CENTERS LONDON IC SHANGHAI IC BEERSE, BE JLABS @ BE March, 2018 JPOD @ PHILADELPHIA November 2018 JLABS Global Reach
  11. 11. 11 Activating Collaborative Local Ecosystems building a coalition of academic institutions, hospitals & industry organizations Centralized Infrastructure providing core capabilities so innovators can dedicate precious capital to the science Educational Programming building skills, knowledge & networks to empower and enable the local innovation community Assets & Experts providing big company support Funding Series connecting capital with innovators to increase the volume and velocity of deal flow Cross-Sector Focus building an environment for solutions not just products Branding a Leading Cluster utilizing corporate resources to brand, launch & promote a region’s innovation No Strings Attached promoting open innovation to support entrepreneurs build equity and value Small Companies Get Big Company Benefits
  12. 12. 12 Perfecting Partnerships for Life Sciences Startup Success 21 MARCH | Basel Moderated by: Stephan Emmerth, Director, Therapeutic Innovation and BaseLaunch @ BaselArea Sascha Bucher Dominik Escher Guenter Huhle Carole Nuechterlein Markus Werner Head of Basel Roivant Pharma and Head of Global Transactions Partner at Pureos Bioventures Head of JLABS EMEA, Johnson & Johnson Innovation Head of Roche Venture Fund VP Partnering of Molecular Partners

×